HRP Anti-Glucose Transporter GLUT1 antibody [EPR3915]
- BOND RX™ Validated
- RabMAb
- KO Validated
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal Glucose Transporter GLUT1 antibody - conjugated to HRP. Suitable for IHC-P, WB and reacts with Human, Mouse, Rat samples. Cited in 2 publications.
View Alternative Names
GLUT1, SLC2A1, HepG2 glucose transporter, GLUT-1
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - HRP Anti-Glucose Transporter GLUT1 antibody [EPR3915] (AB195021)
IHC image of Glucose Transporter GLUT1 staining in a section of formalin-fixed paraffin-embedded normal human colon tissue*, performed on a Leica BOND. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab195021 at 1/100 dilution, for 15 mins at room temperature. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset negative control image is taken from an identical assay without primary antibody.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre
- WB
Lab
Western blot - HRP Anti-Glucose Transporter GLUT1 antibody [EPR3915] (AB195021)
Western blot : HRP Anti-Glucose Transporter GLUT1 antibody [EPR3915] staining at 1/5000 dilution, shown in black; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab195021 was shown to bind specifically to Glucose Transporter GLUT1. A band was observed at 50-300 kDa in wild-type HepG2 cell lysates with no signal observed at this size in SLC2A1 knockout cell line ab280797 (knockout cell lysate ab284224). To generate this image, wild-type and SLC2A1 knockout HepG2 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times before development with Optiblot (ECL reagent ab133456) and imaged with 4 minutes exposure time. Secondary antibodies used were Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - HRP Anti-Glucose Transporter GLUT1 antibody [EPR3915] (ab195021) at 1/5000 dilution
Lane 1:
Wild-type HepG2 cell lysate at 20 µg
Lane 2:
SLC2A1 knockout HepG2 cell lysate at 20 µg
Lane 3:
A549 cell lysate at 20 µg
Lane 4:
Jurkat cell lysate at 20 µg
Observed band size: 50-300 kDa
false
- WB
Lab
Western blot - HRP Anti-Glucose Transporter GLUT1 antibody [EPR3915] (AB195021)
This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 3% milk before being incubated with ab195021 overnight at 4°C. Antibody binding was visualised using ECL development solution ab133406.
All lanes:
Western blot - HRP Anti-Glucose Transporter GLUT1 antibody [EPR3915] (ab195021) at 1/5000 dilution
Lane 1:
Brain (Mouse) Tissue Lysate at 10 µg
Lane 2:
Brain (Human) Tissue Lysate - fetal normal tissue at 10 µg
Predicted band size: 54 kDa
Observed band size: 42 kDa
true
Exposure time: 30s
Related conjugates and formulations (11)
-
578 PE
PE Anti-Glucose Transporter GLUT1 antibody [EPR3915]
-
421 Alexa Fluor® 405
Alexa Fluor® 405 Anti-Glucose Transporter GLUT1 antibody [EPR3915]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Glucose Transporter GLUT1 antibody [EPR3915]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Glucose Transporter GLUT1 antibody [EPR3915]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Glucose Transporter GLUT1 antibody [EPR3915]
-
660 APC
APC Anti-Glucose Transporter GLUT1 antibody [EPR3915]
-
519 FITC
FITC Anti-Glucose Transporter GLUT1 antibody [EPR3915]
-
Biotin Anti-Glucose Transporter GLUT1 antibody [EPR3915]
-
Anti-Glucose Transporter GLUT1 antibody [EPR3915]
-
Anti-Glucose Transporter GLUT1 antibody [EPR3915] - Low endotoxin, Azide free
-
Anti-Glucose Transporter GLUT1 antibody [EPR3915] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This glucose transporter plays a significant role in maintaining glucose homeostasis in the human body. GLUT1 functions independently and not as part of a complex. It ensures that glucose is available to cells with high metabolic demands including the brain and red blood cells where it remains important for survival and function. Its expression level can be influenced by various factors including hypoxia and insulin.
Pathways
GLUT1 is involved in the glycolysis and hypoxia-related pathways. It supports the glycolytic pathway by ensuring a sufficient supply of glucose to the cells which is then metabolized to produce ATP. Additionally during hypoxic conditions GLUT1 expression can increase aligning with proteins like HIF-1α which helps cells adapt by modifying their metabolism. This coordinated regulation permits cells to adjust their energy systems according to the oxygen availability.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
BMC cancer 25:1085 PubMed40597978
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell biology international 45:2063-2073 PubMed34196069
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com